The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expan
What are the Historical Growth Trends in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
The market size for the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) has seen robust growth in recent years. It was projected to increase from $5.53 billion in 2024 to $5.91 billion in 2025. This translates to a Compound Annual Growth Rate (CAGR) of 7.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Industry?
The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) global market is projected to be worth $7.67 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.7%.
Download Your Free Sample of the 2025 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
The key drivers in the investigational new drug contract development and manufacturing organization (cdmo) market are:
• A surge in clinical trials, testing safety and efficacy of medical treatments
• Increased demand for innovative treatments due to escalating rates of chronic and complex diseases
• The role of new drug CDMOs in facilitating the development and manufacturing of trial-ready formulations
• Timely and compliant delivery of investigational products for different study phases by CDMOs.
Global Market Segmentation: Identifying Major Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Industry Segments
The investigational new drug contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Small Molecules, Large Molecules
2) By Formulation Type: Solid Formulations, Liquid Formulations, Injectable Formulations
3) By Service Type: Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services
4) By End-User: Biotechnology Companies, Academic And Research Institutes, Other End-Users
Pre-order the 2025 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
The key trends in the investigational new drug contract development and manufacturing organization (cdmo) market are:
• The trend of strategic partnerships is growing within the CDMO market as companies aim to enhance their development and production capabilities.
• These collaborations allow organizations to leverage each other's strengths and resources while maintaining their independence.
• Such alliances can help in accelerating entry into clinical processes.
• Companies are also focusing on innovative bioprocessing solutions as part of their commitment to grow within the biomanufacturing industry.
Who Are the Top Competitors & Leading Players in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Major players in the investigational new drug contract development and manufacturing organization (cdmo) market are:
• Thermo Fisher Scientific Inc.
• Fresenius Kabi AG
• Lonza Group Ltd.
• Catalent Inc.
• Samsung Biologics Co. Ltd.
• Fareva SA
• Recipharm AB
• PCI Pharma Services
• Vetter Pharma
• Delpharm
• Kindeva Drug Delivery LP
• Ajinomoto Bio-Pharma Services
• Cenexi SAS
• Grand River Aseptic Manufacturing Inc.
• INCOG BioPharma Services
• Aurigene Pharmaceutical Services
• Jubilant HollisterStier LLC
• Symbiosis Pharmaceutical Services Ltd.
• Afton Scientific Corp.
• Amaran Biotech Inc.
Regional Dominance: Which Area Leads the Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2024
